Cargando…
The impact of microfluidics in high-throughput drug-screening applications
Drug discovery is an expensive and lengthy process. Among the different phases, drug discovery and preclinical trials play an important role as only 5–10 of all drugs that begin preclinical tests proceed to clinical trials. Indeed, current high-throughput screening technologies are very expensive, a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142169/ https://www.ncbi.nlm.nih.gov/pubmed/35646223 http://dx.doi.org/10.1063/5.0087294 |
_version_ | 1784715513065111552 |
---|---|
author | De Stefano, Paola Bianchi, Elena Dubini, Gabriele |
author_facet | De Stefano, Paola Bianchi, Elena Dubini, Gabriele |
author_sort | De Stefano, Paola |
collection | PubMed |
description | Drug discovery is an expensive and lengthy process. Among the different phases, drug discovery and preclinical trials play an important role as only 5–10 of all drugs that begin preclinical tests proceed to clinical trials. Indeed, current high-throughput screening technologies are very expensive, as they are unable to dispense small liquid volumes in an accurate and quick way. Moreover, despite being simple and fast, drug screening assays are usually performed under static conditions, thus failing to recapitulate tissue-specific architecture and biomechanical cues present in vivo even in the case of 3D models. On the contrary, microfluidics might offer a more rapid and cost-effective alternative. Although considered incompatible with high-throughput systems for years, technological advancements have demonstrated how this gap is rapidly reducing. In this Review, we want to further outline the role of microfluidics in high-throughput drug screening applications by looking at the multiple strategies for cell seeding, compartmentalization, continuous flow, stimuli administration (e.g., drug gradients or shear stresses), and single-cell analyses. |
format | Online Article Text |
id | pubmed-9142169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AIP Publishing LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-91421692022-05-28 The impact of microfluidics in high-throughput drug-screening applications De Stefano, Paola Bianchi, Elena Dubini, Gabriele Biomicrofluidics Review Articles Drug discovery is an expensive and lengthy process. Among the different phases, drug discovery and preclinical trials play an important role as only 5–10 of all drugs that begin preclinical tests proceed to clinical trials. Indeed, current high-throughput screening technologies are very expensive, as they are unable to dispense small liquid volumes in an accurate and quick way. Moreover, despite being simple and fast, drug screening assays are usually performed under static conditions, thus failing to recapitulate tissue-specific architecture and biomechanical cues present in vivo even in the case of 3D models. On the contrary, microfluidics might offer a more rapid and cost-effective alternative. Although considered incompatible with high-throughput systems for years, technological advancements have demonstrated how this gap is rapidly reducing. In this Review, we want to further outline the role of microfluidics in high-throughput drug screening applications by looking at the multiple strategies for cell seeding, compartmentalization, continuous flow, stimuli administration (e.g., drug gradients or shear stresses), and single-cell analyses. AIP Publishing LLC 2022-05-26 /pmc/articles/PMC9142169/ /pubmed/35646223 http://dx.doi.org/10.1063/5.0087294 Text en © 2022 Author(s). https://creativecommons.org/licenses/by/4.0/All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review Articles De Stefano, Paola Bianchi, Elena Dubini, Gabriele The impact of microfluidics in high-throughput drug-screening applications |
title | The impact of microfluidics in high-throughput drug-screening applications |
title_full | The impact of microfluidics in high-throughput drug-screening applications |
title_fullStr | The impact of microfluidics in high-throughput drug-screening applications |
title_full_unstemmed | The impact of microfluidics in high-throughput drug-screening applications |
title_short | The impact of microfluidics in high-throughput drug-screening applications |
title_sort | impact of microfluidics in high-throughput drug-screening applications |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142169/ https://www.ncbi.nlm.nih.gov/pubmed/35646223 http://dx.doi.org/10.1063/5.0087294 |
work_keys_str_mv | AT destefanopaola theimpactofmicrofluidicsinhighthroughputdrugscreeningapplications AT bianchielena theimpactofmicrofluidicsinhighthroughputdrugscreeningapplications AT dubinigabriele theimpactofmicrofluidicsinhighthroughputdrugscreeningapplications AT destefanopaola impactofmicrofluidicsinhighthroughputdrugscreeningapplications AT bianchielena impactofmicrofluidicsinhighthroughputdrugscreeningapplications AT dubinigabriele impactofmicrofluidicsinhighthroughputdrugscreeningapplications |